Laclarée is a medical technology company headquartered in Lyon, France, that develops autofocussing eyeglasses designed to correct presbyopia.
Subscribe to see Laclarée’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Laclarée is a therapeutic devices company headquartered in Lyon, France. It has raised at least $5.8M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $3.8M in February 2025. Xcout tracks 1 named person at Laclarée, including Bruno Berge (founder and CEO).
As of 16 November 2026. Source: Xcout Intel.
At least $5.8M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3.8M | 5 named | |
| Seed | $2M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 5 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Laclarée's closest competitors — see the full list of competitors and alternatives →
Lentechs is a clinical-stage ophthalmic medical device company that develops patented soft, suspended contact lenses designed for individuals with presbyopia. Its technology is engineered to be suspended behind the upper eyelid to allow free eye movement behind a rotationally-stable lens, providing vision correction at multiple distances.
Adaptilens, Inc. is an ophthalmic medical device company headquartered near Boston, Massachusetts, focused on developing advanced accommodating intraocular lenses (IOLs). Founded by ophthalmic device inventors, the company aims to restore natural range of vision for cataract patients through innovative lens technologies. It conducts clinical evaluations and secures venture backing to advance its medical device pipeline.
Ocumetics Technology Corp. is an innovation-driven enterprise specializing in the development and production of diverse optical lenses. One of its key innovations is the Bionic Lens, an expandable intraocular lens crafted to be implanted within the eye's natural lens compartment, offering a solution that eliminates the need for external vision correction. The company maintains its corporate headquarters in Calgary, Canada.
Sensimed S.A. is a Swiss medical device company based in Etagnières, Switzerland, known for developing the SENSIMED Triggerfish non-invasive smart contact lens.
AcuFocus, Inc. is a privately held ophthalmic medical device company headquartered in Irvine, California. The firm focuses on the development and commercialization of innovative technologies for treating various eye conditions.
UroMems is a global medical device and biotechnology company headquartered in Eybens, France, developing innovative mechatronic implants like the UroActive system to treat urinary incontinence.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Laclarée? Suggest a correction · Work at Laclarée? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.